These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 6731457)
21. Visual compatibility of nalbuphine hydrochloride and promethazine hydrochloride. Jimenez MD Am J Hosp Pharm; 1988 Jun; 45(6):1278. PubMed ID: 3414694 [No Abstract] [Full Text] [Related]
22. Visual compatibility of morphine sulfate and meperidine hydrochloride with other injectable drugs during simulated Y-site injection. Pugh CB; Pabis DJ; Rodriguez C Am J Hosp Pharm; 1991 Jan; 48(1):123-5. PubMed ID: 2000871 [No Abstract] [Full Text] [Related]
23. Visual compatibility of acyclovir sodium with commonly used intravenous drugs simulated Y-site injection. Forman JK; Lachs JR; Souney PF Am J Hosp Pharm; 1987 Jun; 44(6):1408-9. PubMed ID: 3618621 [No Abstract] [Full Text] [Related]
24. Visual compatibility of haloperidol lactate with injectable solutions. Fraser GL; Riker RR Am J Hosp Pharm; 1994 Apr; 51(7):905-6. PubMed ID: 8017441 [No Abstract] [Full Text] [Related]
25. Physical compatibility of levetiracetam injection with heparin, dobutamine, and dopamine. Cruz KCE; Churchwell MD; Mauro VF; Boddu SHS Am J Health Syst Pharm; 2018 Apr; 75(8):510-512. PubMed ID: 29626000 [No Abstract] [Full Text] [Related]
26. Visual compatibility of hydroxyzine hydrochloride with various antineoplastic agents. Marquardt ED Am J Hosp Pharm; 1988 Oct; 45(10):2127. PubMed ID: 3228084 [No Abstract] [Full Text] [Related]
27. Stability of dobutamine hydrochloride in selected large-volume parenterals. Kirschenbaum HL; Aronoff W; Perentesis GP; Piltz GW; Goldberg RJ; Cutie AJ Am J Hosp Pharm; 1982 Nov; 39(11):1923-5. PubMed ID: 7148861 [TBL] [Abstract][Full Text] [Related]
28. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. Trissel LA; Williams KY; Gilbert DL J Am Pharm Assoc (Wash); 2000; 40(4):515-9. PubMed ID: 10932461 [TBL] [Abstract][Full Text] [Related]
29. Clarification of visual compatibility of hetastarch and ranitidine hydrochloride. Wohlford JG Am J Hosp Pharm; 1989 Sep; 46(9):1772. PubMed ID: 2478014 [No Abstract] [Full Text] [Related]
30. Compatibility of propranolol hydrochloride injection with intravenous infusion fluids in plastic containers. Cummings DS; Park MK; Howard AB Am J Hosp Pharm; 1982 Oct; 39(10):1685-7. PubMed ID: 7148843 [TBL] [Abstract][Full Text] [Related]
31. Compatibility of verapamil hydrochloride with other additives. Cutie MR Am J Hosp Pharm; 1981 Feb; 38(2):231. PubMed ID: 7211888 [No Abstract] [Full Text] [Related]
32. Compatibility of drugs separated by a fluid barrier in a retrograde intravenous infusion system. Garner SS; Wiest DB Am J Hosp Pharm; 1990 Mar; 47(3):604-6. PubMed ID: 2107740 [No Abstract] [Full Text] [Related]
33. Stability and compatibility of minocycline hydrochloride and rifampin in intravenous solutions at various temperatures. Pearson SD; Trissel LA Am J Hosp Pharm; 1993 Apr; 50(4):698-702. PubMed ID: 8470688 [TBL] [Abstract][Full Text] [Related]
34. Visual compatibility of insulin with secondary intravenous drugs in admixtures. Smythe M; Malouf E Am J Hosp Pharm; 1991 Jan; 48(1):125-6. PubMed ID: 2000872 [No Abstract] [Full Text] [Related]
35. Visual compatibility of ceftizoxime sodium in four electrolyte injections. Swenson E; Gooch WM; Higbee MD Am J Hosp Pharm; 1986 Sep; 43(9):2242-4. PubMed ID: 3766586 [No Abstract] [Full Text] [Related]
36. Visual compatibility of vasopressin with other injectable drugs. Barker B; Feddema S; Rusho WJ; Dengg R Am J Health Syst Pharm; 2005 Oct; 62(19):1969, 1975-76. PubMed ID: 16174827 [No Abstract] [Full Text] [Related]
37. Visual compatibility of narcotic analgesics with selected intravenous admixtures. Smythe MA; Patel MA; Gasloli RA Am J Hosp Pharm; 1990 Apr; 47(4):819-20. PubMed ID: 1969712 [No Abstract] [Full Text] [Related]